Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

February 28, 2019
Govert W. Somsen

,
Rob Haselberg

,
Klara Michalikova

,
Elena Dominguez-Vega

,
Miroslav Polasek

LCGC Europe

LCGC Europe, LCGC Europe-03-01-2019, Volume 32, Issue 3

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis-Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.